NAZCA

About global climate action Close

Global Climate Action  

At the twenty-first session of the Conference of the Parties (COP 21) in Paris, it was agreed that mobilizing stronger and more ambitious climate action by all Parties and non-Party stakeholders is urgently required if the goals of the Paris Agreement are to be achieved.

In decision 1/CP.21, the commitments from all actors are recognized, including those launched through the Lima–Paris Action Agenda, as well as the urgent need to scale up the global response to climate change and support greater ambition from governments.

At COP 22 in Marrakech, a High-Level Event on Accelerating Climate Action was held to highlight outcomes from the Action Events throughout the conference and culminated with the launching of the Marrakech Partnership for Global Climate Action; a new framework to catalyse and support climate action.

NAZCA Tracking Climate Action

Search

Browse

Join

Register your commitments
52

Pharmaceuticals, Biotechnology, and Life Sciences

SELECT A COMPANY

AbbVie

United States of America

Agilent Technologies

United States of America

Allergan

United States of America

Alps Pharmaceutical Industry Co., Ltd.

Japan

Amgen, Inc.

United States of America

Astellas Pharma Inc.

Japan

AstraZeneca

United Kingdom of Great Britain and Northern Ireland

Bayer AG

Germany

BioGaia

Sweden

Biogen

United States of America

Bristol-Myers Squibb

United States of America

Catalent Pharma Solutions

United States of America

Chugai Pharmaceutical Co., Ltd.

Japan

CSL

Australia

Daiichi Sankyo Co., Ltd.

Japan

Dainippon Sumitomo Pharma Co., Ltd.

Japan

Dr. Reddy’s Laboratories

India

Eisai Co., Ltd.

Japan

Eli Lilly and Company

United States of America

Esteve

Spain

GlaxoSmithKline

United Kingdom of Great Britain and Northern Ireland

Grifols

Spain

Groupe Bial

Portugal

Hikma Pharmaceuticals

United Kingdom of Great Britain and Northern Ireland

Hospira, Inc.

United States of America

Johnson & Johnson

United States of America

Jubilant Life Sciences Ltd

India

LG Life Sciences

Republic of Korea

Lonza Group AG

Switzerland

Lundbeck A/S

Denmark

Meda AB

Sweden

Merck & Co., Inc.

United States of America

Merck KGaA

Germany

Mettler-Toledo

Switzerland

Novartis

Switzerland

Novo Nordisk

Denmark

Ono Pharmaceutical Co., Ltd.

Japan

PerkinElmer, Inc.

United States of America

Pfizer Inc.

United States of America

Piramal Enterprises

India

Regeneron Pharmaceuticals, Inc.

United States of America

Roche Holding AG

Switzerland

SANOFI

France

Shire

Ireland

Takeda Pharmaceutical Company Limited

Japan

Teva Pharmaceutical Industries Ltd

Israel

Thermo Fisher Scientific Inc.

United States of America

TSI

United Kingdom of Great Britain and Northern Ireland

Valeant Pharmaceuticals International, Inc.

United States of America

Waters Corporation

United States of America

Yves Rocher Group

France

ZCL Chemicals

India